# Biotech Investor Deep-Dive Report: Angels, VCs & Family Offices
**Generated:** February 11, 2026

---

## Executive Summary
50+ biotech seed/angel investors actively deploying capital. Key insight: Production skills matter more than credentials; depth over breadth wins.

---

## TIER 1: BIOTECH-FOCUSED VCs (Seed/Early Stage)

### 1. 5AM Ventures
- **Focus:** Life science companies
- **Stage:** Early stage
- **Specialty:** Breakthrough biotech, pharma, medtech
- **Website:** 5amventures.com

### 2. ARCH Venture Partners ⭐
- **Focus:** Life sciences, physical sciences
- **Stage:** Early-stage company development
- **Known for:** Disruptive biotech technologies
- **Note:** Very active, influential

### 3. IndieBio (SOSV) ⭐
- **Type:** Accelerator + investment
- **Investment:** $500K seed funding
- **Bonus:** Lab space, mentorship
- **Focus:** Revolutionary biotech/life sciences
- **Why apply:** Fast track from concept to product

### 4. Flagship Pioneering
- **Known for:** Moderna
- **Approach:** Incubate from ground up
- **Stage:** Earliest stage
- **Note:** Very selective, usually creates companies internally

### 5. Canaan Partners
- **Focus:** Early-stage, transformative ideas
- **Sectors:** Biotech, healthcare, fintech
- **Website:** canaan.com

### 6. 8VC
- **Focus:** High-tech and biotech
- **Approach:** Forward-thinking, industry transformation
- **Founded by:** Joe Lonsdale

### 7. Founders Fund
- **Focus:** Multi-sector including biotech
- **Philosophy:** Entrepreneur-friendly
- **Notable:** Backed several high-profile biotech startups

---

## TIER 2: SPECIALIZED BIOTECH INVESTORS

### Oncology-Specific

**Aglaia Oncology Funds** ⭐
- **Focus:** ONLY oncology
- **Stage:** Early-stage breakthrough inventions
- **Interest:** Cancer prevention, diagnosis, therapy
- **Website:** aglaia-oncology.com
- **Why contact:** Perfect mission alignment

**Forward Ventures (San Diego)**
- **Focus:** Life science, healthcare, medtech
- **Stage:** Early and late stage
- **Founded:** 1990

### Diagnostics/Devices

**Codon Capital**
- **Focus:** Life sciences, healthcare
- **Specialty:** Therapeutic, diagnostic, service solutions
- **Website:** codoncapital.com

**Curie.Bio**
- **Focus:** Early-stage biotech
- **Interest:** Technologies with significant healthcare impact

### Longevity/Aging

**Apollo Health Ventures**
- **Focus:** Aging and longevity
- **Approach:** Venture capital + deep scientific expertise

**Cambrian Bio**
- **Focus:** Therapeutics for causes of aging
- **Stage:** Early-stage

---

## TIER 3: MULTI-SECTOR VCs WITH BIOTECH INTEREST

### Active in Biotech

| Firm | Focus | Notes |
|------|-------|-------|
| DCVC | Deep tech + biotech | Computational biology |
| Fifty Years VC | World's biggest problems | Impact + returns |
| Breakout Ventures | Scientific revolution | Thiel Foundation origin |
| Boom Capital | Bio + tech intersection | Seed stage |
| Axial VC | Biotech + computational | Data/ML in biotech |

---

## FAMILY OFFICES (Biotech-Interested)

### Known Biotech Investors

**1. Tarsadia Investments**
- Backed: Asana Biosciences
- Focus: Life sciences, R&D companies
- Type: Single Family Office

**2. Pritzker Group**
- Family: Pritzker (Hyatt, etc.)
- Has made healthcare investments

**3. Emerson Collective**
- Founder: Laurene Powell Jobs
- Active in health innovation

### How to Approach Family Offices
1. Warm intro preferred (always)
2. Mission alignment matters more than returns pitch
3. Longer time horizons than VCs
4. Often do smaller checks, more patient

---

## CORPORATE VENTURE ARMS

### Pharma CVCs

| CVC | Parent | Focus |
|-----|--------|-------|
| Boehringer Ingelheim Venture Fund | Boehringer Ingelheim | Novel therapeutics |
| Johnson & Johnson Innovation | J&J | Broad healthcare |
| Pfizer Ventures | Pfizer | Pharma, biotech |
| Roche Venture Fund | Roche | Diagnostics, pharma |
| Novartis Venture Fund | Novartis | Biotech |

### Device Company CVCs

| CVC | Parent | Focus |
|-----|--------|-------|
| Medtronic LABS | Medtronic | Healthcare innovation |
| Abbott Ventures | Abbott | Diagnostics, devices |
| Boston Scientific | Boston Scientific | Medtech |

---

## INVESTOR DATABASE RESOURCES

### Free
- **OpenVC.app** — biotech investor lists
- **AngelList** — angel investors
- **Crunchbase** — funding data
- **LinkedIn** — investor connections

### Paid
- **Tracxn** — comprehensive investor data
- **PitchBook** — institutional data
- **CB Insights** — market intelligence

---

## KELLY'S WARM NETWORK

### Already Connected
- **Jim Armstrong** — Forbes Midas List, early PayPal investor (Interim CFO)
- **Andy Lehman** — The Mill accelerator connections
- **Emily Atkinson** — IU Ventures
- **Flywheel Fund** — IU network

### To Activate
- IU Kelley School alumni network
- LA biotech community
- Toronto/Waterloo network via Nirosha

---

## PITCH PRIORITIES

### Best Fit for HelioFlux

1. **Aglaia Oncology** — Mission-perfect (oncology only)
2. **IndieBio** — Accelerator + funding + validation
3. **Codon Capital** — Diagnostics focus
4. **Boehringer Ingelheim Venture** — Corporate + early stage
5. **ARCH Venture** — Disruptive biotech focus

### Approach Strategy

**Phase 1: Warm intros**
- Jim Armstrong connections
- IU network
- Andy Lehman introductions

**Phase 2: Cold outreach**
- Targeted emails with Maya story hook
- Interactive patient journey link
- Clear ask

**Phase 3: Applications**
- IndieBio accelerator
- Y Combinator (diagnostics track)
- Other accelerator programs

---

## INVESTOR OUTREACH TEMPLATE

**Subject:** HelioFlux: 100x Earlier Cancer Detection (Non-invasive)

**Body:**
[Name],

What if we could detect cancer 100x earlier than current methods — with a 5-minute, non-invasive scan?

HelioFlux reads ultra-weak photon emissions from cells. Cancer cells glow differently. We've published in iScience (2025) and are now building a clinical-grade device.

[Brief ask — intro, meeting, pitch deck review]

Interactive demo: [link to patient journey]

Best,
Kelly Lucas
President, HelioFlux

---

## ACTION ITEMS

- [ ] Research Aglaia Oncology application process
- [ ] Check IndieBio application timeline
- [ ] Draft targeted emails for top 5 investors
- [ ] Ask Jim Armstrong for specific introductions
- [ ] Update CRM with investor targets

---

*Sources: Excedr, OpenVC, AngelList, Fierce Biotech, company websites*
